Despite the COVID-19 dilemma, the worldwide market for Mannequin-Based Simulation, estimated at US$1.2 billion in 2020, is expected to reach US$5 billion by 2027, rising at a CAGR of 22% between 2020 and 2027.
Patient Simulators, one of the report's sectors, is expected to grow at an 18.5 percent CAGR and reach US$2.7 billion by the conclusion of the study period. Following an early assessment of the commercial ramifications of the pandemic and the resulting economic crisis, growth in the Other Product Segments category is revised to a revised 27.7 percent CAGR over the following seven years.
In the United States, the Mannequin-Based Simulation industry is expected to be worth US$367.5 million by 2020. China, the world's second biggest economy, is expected to reach a market size of US$876.2 million by 2027, growing at a CAGR of 21.7 percent from 2020 to 2027.
Other notable geographic markets include Japan and Canada, which are expected to increase at 19.2 percent and 19 percent, respectively, between 2020 and 2027. Germany is expected to expand at a CAGR of about 15.6 percent in Europe.
This analysis provides qualitative information sets such as drivers, obstacles, and future prospects, as well as important commercial and research events in the worldwide mannequin-based simulation industry. This paper presents tools for analyzing competitiveness in the worldwide mannequin-based simulation business, such as fractal map analysis and appealing investment propositions. This report finishes with a section on business profiles that emphasizes information on the important firms involved in the development, manufacture, and provision of mannequin-based simulation solutions.